Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients
- PMID: 22784688
- DOI: 10.1016/j.schres.2012.06.025
Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients
Abstract
Patients with schizophrenia show deficits in motivation, reward anticipation and salience attribution. Several functional magnetic resonance imaging (fMRI) investigations revealed neurobiological correlates of these deficits, raising the hypothesis of a common basis in midbrain dopaminergic signaling. However, investigations of drug-naïve first-episode patients with comprehensive fMRI tasks are still missing. We recruited unmedicated schizophrenia spectrum patients (N=27) and healthy control subjects (N=27) matched for sex, age and educational levels. An established monetary reward anticipation task in combination with a novel task aiming at implicit salience attribution without the confound of monetary incentive was applied. Patients showed reduced right ventral striatal activation during reward anticipation. Furthermore, patients with a more pronounced hypoactivation attributed more salience to neutral stimuli, had more positive symptoms and better executive functioning. In the patient group, a more differentially active striatum during reward anticipation was correlated positively to differential ventral striatal activation in the implicit salience attribution task. In conclusion, a deficit in ventral striatal activation during reward anticipation can already be seen in drug-naïve, first episode schizophrenia patients. The data suggest that rather a deficit in differential ventral striatal activation than a generally reduced activation underlies motivational deficits in schizophrenia and that this deficit is related to the aberrant salience attribution.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.JAMA Psychiatry. 2014 May;71(5):531-9. doi: 10.1001/jamapsychiatry.2014.9. JAMA Psychiatry. 2014. PMID: 24622944
-
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.Psychopharmacology (Berl). 2006 Aug;187(2):222-8. doi: 10.1007/s00213-006-0405-4. Epub 2006 May 24. Psychopharmacology (Berl). 2006. PMID: 16721614
-
Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder.Biol Psychiatry. 2007 Mar 1;61(5):720-4. doi: 10.1016/j.biopsych.2006.04.042. Epub 2006 Sep 1. Biol Psychiatry. 2007. PMID: 16950228
-
Neurobiological correlates of delusion: beyond the salience attribution hypothesis.Neuropsychobiology. 2012;66(1):33-43. doi: 10.1159/000337132. Epub 2012 Jul 13. Neuropsychobiology. 2012. PMID: 22797275 Review.
-
Dopaminergic dysfunction in schizophrenia: salience attribution revisited.Schizophr Bull. 2010 May;36(3):472-85. doi: 10.1093/schbul/sbq031. Epub 2010 May 7. Schizophr Bull. 2010. PMID: 20453041 Free PMC article. Review.
Cited by
-
A Review of Anticipatory Pleasure in Schizophrenia.Curr Behav Neurosci Rep. 2016 Sep;3(3):232-247. doi: 10.1007/s40473-016-0082-5. Epub 2016 Jun 30. Curr Behav Neurosci Rep. 2016. PMID: 27980891 Free PMC article.
-
The effect of risperidone on reward-related brain activity is robust to drug-induced vascular changes.Hum Brain Mapp. 2021 Jun 15;42(9):2766-2777. doi: 10.1002/hbm.25400. Epub 2021 Mar 5. Hum Brain Mapp. 2021. PMID: 33666305 Free PMC article. Clinical Trial.
-
Neurobiological background of negative symptoms.Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):543-58. doi: 10.1007/s00406-015-0590-4. Epub 2015 Mar 24. Eur Arch Psychiatry Clin Neurosci. 2015. PMID: 25797499 Review.
-
Diagnostic classification of schizophrenia patients on the basis of regional reward-related FMRI signal patterns.PLoS One. 2015 Mar 23;10(3):e0119089. doi: 10.1371/journal.pone.0119089. eCollection 2015. PLoS One. 2015. PMID: 25799236 Free PMC article.
-
The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.Eur Neuropsychopharmacol. 2014 May;24(5):725-36. doi: 10.1016/j.euroneuro.2013.06.007. Epub 2014 Jan 22. Eur Neuropsychopharmacol. 2014. PMID: 24461724 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical